147 related articles for article (PubMed ID: 8739663)
1. A naturalistic 6-year follow-up study of patients with panic disorder.
Lepola U; Koponen H; Leinonen E
Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
[TBL] [Abstract][Full Text] [Related]
2. A 15-year follow-up study of patients with panic disorder.
Andersch S; Hetta J
Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
[TBL] [Abstract][Full Text] [Related]
3. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
4. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up after a drug trial for panic disorder.
Katschnig H; Amering M; Stolk JM; Klerman GL; Ballenger JC; Briggs A; Buller R; Cassano G; Garvey M; Roth M
Br J Psychiatry; 1995 Oct; 167(4):487-94. PubMed ID: 8829718
[TBL] [Abstract][Full Text] [Related]
6. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
[TBL] [Abstract][Full Text] [Related]
8. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
[TBL] [Abstract][Full Text] [Related]
9. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
Lepola U; Arató M; Zhu Y; Austin C
J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
[TBL] [Abstract][Full Text] [Related]
10. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
11. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
Biol Psychiatry; 1995 Dec; 38(11):737-41. PubMed ID: 8580226
[TBL] [Abstract][Full Text] [Related]
13. Suicide and violence associated with panic attacks.
Korn ML; Kotler M; Molcho A; Botsis AJ; Grosz D; Chen C; Plutchik R; Brown SL; van Praag HM
Biol Psychiatry; 1992 Mar; 31(6):607-12. PubMed ID: 1581440
[TBL] [Abstract][Full Text] [Related]
14. Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
Albus M; Scheibe G; Scherer J
J Affect Disord; 1995 May; 34(2):109-15. PubMed ID: 7665802
[TBL] [Abstract][Full Text] [Related]
15. Personality dimensions in panic disorder before and after effective treatment.
Starcevic V; Uhlenhuth EH
Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
[No Abstract] [Full Text] [Related]
16. Psychopharmacological treatment of panic disorder.
Bowden CL
Bull Menninger Clin; 1992; 56(2 Suppl A):A29-41. PubMed ID: 1623338
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of panic disorder.
Rosenberg R
Pharmacol Toxicol; 1993 Jun; 72(6):344-53. PubMed ID: 8103214
[TBL] [Abstract][Full Text] [Related]
18. Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.
Lepola UM; Rimón RH; Riekkinen PJ
Int Clin Psychopharmacol; 1993; 8(2):115-8. PubMed ID: 8345160
[TBL] [Abstract][Full Text] [Related]
19. Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
Albus M; Scheibe G; Scherer J
Psychopathology; 1995; 28(5):229-34. PubMed ID: 8559945
[TBL] [Abstract][Full Text] [Related]
20. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
Westenberg HG
J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]